CATALYST FINANCIAL PARTNERS LLC

Position in ABOS — Acumen Pharmaceuticals, Inc.

CIK 1927537 BOSTON, MA

Position in ABOS

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$211,689

+$22,425 QoQ

Shares Held

89,699

0.0% QoQ

Ownership

0.124%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#31

of 84 holders

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

CATALYST FINANCIAL PARTNERS LLC holds $1,567,578 across 4 Biotechnology names. ABOS ranks #4 (13.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,654	$738,577
2	REGN	Regeneron Pharmaceuticals, Inc.	462	$356,959
3	DMAC	DiaMedica Therapeutics Inc.	38,457	$260,353
4	ABOS	Acumen Pharmaceuticals, Inc. This page	89,699	$211,689

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$211,689	89,699	0.0%	Shares	Sole	2026-05-12
2025-12-31	$189,264	89,699	0.0%	Shares	Sole	2026-02-04
2025-09-30	$153,385	89,699	0.0%	Shares	Sole	2025-11-12
2025-06-30	$104,050	89,699	0.0%	Shares	Sole	2025-08-14
2025-03-31	$98,668	89,699	0.0%	Shares	Sole	2025-05-02
2024-12-31	$154,282	89,699	0.0%	Shares	Sole	2025-01-30
2024-09-30	$222,453	89,699	0.0%	Shares	Sole	2024-10-28
2024-06-30	$217,071	89,699	0.0%	Shares	Sole	2024-07-25
2024-03-31	$363,280	89,699	0.0%	Shares	Sole	2024-04-23
2023-12-31	$344,444	89,699	0.0%	Shares	Sole	2024-02-07
2023-09-30	$372,250	89,699	0.0%	Shares	Sole	2023-10-26
2023-06-30	$431,452	89,699	—	Shares	Sole	2023-08-02
No filing history on record for this holder in this stock.